Hadron Beam Therapy 25/04/2024

Pre-commercial Public Procurement Phase I for the development of innovative solutions in the field of compact linear ion accelerators.

Compact linear ion accelerators are a technique that is emerging as one of the most effective future therapies in radiological treatments against cancer.

Protons (particles that form the nucleus of the atom) and ions (atoms with electric charge) allow modulation of irradiation on tumor tissues with great precision, with much less damage to healthy tissue than conventional radiotherapy using photons (X-rays).

Treatment with protons or ions is especially recommended for pediatric cases and radio-resistant tumors. Additionally, ions exhibit greater radiobiological efficacy, even lower toxicity, and a more favorable immune response than protons.

The real challenge is the generalization of their accessibility since they are currently unique, scarce, large-scale, and expensive equipment worldwide. Hence the need for an innovation process that simplifies equipment instrumentation and also enables the conversion of hospital spaces currently used to facilitate further expansion of this therapy and its application to those patients in need.

This contract is co-financed by CDTI's own assets and by European funds from the European Regional Development Fund (ERDF) established by Regulation (EU) 2021/1058 of the European Parliament and of the Council of June 24, 2021, on the European Regional Development Fund and the Cohesion Fund.